首页> 外国专利> Recombinant DNA molecule, host cell, methods to prolong tissue graft survival, to increase the response to exogenous interferon therapy in the treatment of cancer and to provide an ifnar! Receptor binding protein, and, ifnar1 binding protein .

Recombinant DNA molecule, host cell, methods to prolong tissue graft survival, to increase the response to exogenous interferon therapy in the treatment of cancer and to provide an ifnar! Receptor binding protein, and, ifnar1 binding protein .

机译:重组DNA分子,宿主细胞,延长组织移植物存活,增加对癌症治疗的外源干扰素治疗反应的方法,以及提供一种方法。受体结合蛋白和ifnar1结合蛋白。

摘要

"RECOMBINANT DNA MOLECULES, HOSTING CELL, METHODS TO EXTEND TISSUE GRAFT SURVIVAL, TO INCREASE THE RESPONSE TO EXOGEN THERAPY BY INTERFERON IN THE TREATMENT OF CANCER AND TO PROVIDE A PROTECTION OF LIGATION AND A PROTEIN OF LIGATION ". New proteins IR1B1 AND IR1B4 have been isolated, which bind to IFNAR1 of the type I IFN receptor and function in the cellular response to IFNs. The DNA encoding such proteins, in the sense or antisense orientation, can be administered to increase or inhibit the cellular response to IFNs. Antibodies to proteins can be used to isolate new proteins or to immunodetect them.
机译:“重组DNA分子,细胞,延长组织移植物存活率的方法,通过干扰素治疗癌症来增强对外源疗法的反应,并提供对结扎和结扎蛋白的保护”。已分离出新蛋白IR1B1和IR1B4,它们与I型IFN受体的IFNAR1结合并在细胞对IFN的反应中起作用。可以以有义或反义方向施用编码此类蛋白质的DNA,以增加或抑制细胞对IFN的反应。蛋白质抗体可用于分离新蛋白质或免疫检测它们。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号